A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Clinical trial NCT02232620 · TERMINATED
Trial details
- NCT number
- NCT02232620
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2017-07-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.